Melanoma-Specific Clinical Outcomes of Inpatient Immune Checkpoint Blockade Treatment

BACKGROUND: Little is known about patient outcomes with advanced melanoma following inpatient initiation or continuation of immune checkpoint blockade (ICB). METHODS AND RESULTS: We conducted a single institution retrospective case series of advanced melanoma patients who initiated ICB as an inpatie...

Descripción completa

Detalles Bibliográficos
Autores principales: Loo, Kimberly, Kalvin, Hannah L, Panageas, Katherine S, Park, Vivian, Postow, Michael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438908/
https://www.ncbi.nlm.nih.gov/pubmed/35766876
http://dx.doi.org/10.1093/oncolo/oyac121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438908/
https://www.ncbi.nlm.nih.gov/pubmed/35766876
http://dx.doi.org/10.1093/oncolo/oyac121

Ejemplares similares